Dr. Weijing Sun, MD

Dr. Sun practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Sun's NPI, 1811925316, was assigned on June 30, 2006. Dr. Sun holds Kansas license 04-40176.

Dr. Sun's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Sun's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Sun is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is KU Dental Associates. Dmand AI also links Dr. Sun to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sun practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Sun's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Sun's licenses on file in 2 states: Kansas and Missouri.

CMS data shows 927 Medicare services from Dr. Sun across 6 procedure codes in 2024, for 205 Medicare patients. Medicare paid $61,502 for them.

CMS counts 205 Medicare patients who saw Dr. Sun in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sun's median patient age at 71, with 44% women.

In 2024, Dr. Sun wrote 466 Medicare Part D claims for 88 patients. 72% of them were for generic drugs. CMS names the drug for 324 of them, across 13 drugs with 11 or more claims each, at $1,214,101 in total drug cost. In 2023, CMS named 161 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sun for performance year 2024, reported through an alternative payment model (APM). Dr. Sun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sun as offering telehealth.

Dmand AI links 108 papers to Dr. Sun, published from 2009 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Antineoplastic Agents. Dr. Sun has published most often in Phys Rev Lett. Dr. Sun's most frequent co-authors are Joaquina Celebre Baranda, MD, Robin Park and Stephen K. Williamson, MD.

CMS Open Payments shows 250 general payments to Dr. Sun from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $49,720.